The Chicago Entrepreneur

Scholar Rock’s stock soars more than 230% on positive trial of treatment for spinal muscular atrophy

The Phase 3 trial of Apitegromab showed statistically significant improvement in motor function.

Previous post Effective Ways How To Protect Your Family From Harm’s Way
Next post Apple’s stock draws a downgrade as AI optimism may be very premature